World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transthyretin amyloid cardiomyopathy can be either age-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Brito, Dulce, Albrecht, Fabiano Castro, de Arenaza, Diego Perez, Bart, Nicole, Better, Nathan, Carvajal-Juarez, Isabel, Conceição, Isabel, Damy, Thibaud, Dorbala, Sharmila, Fidalgo, Jean-Christophe, Garcia-Pavia, Pablo, Ge, Junbo, Gillmore, Julian D., Grzybowski, Jacek, Obici, Laura, Piñero, Daniel, Rapezzi, Claudio, Ueda, Mitsuharu, Pinto, Fausto J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2023
Materias:
Official WHF document
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607607/
https://www.ncbi.nlm.nih.gov/pubmed/37901600
http://dx.doi.org/10.5334/gh.1262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607607/
https://www.ncbi.nlm.nih.gov/pubmed/37901600
http://dx.doi.org/10.5334/gh.1262

Ejemplares similares